Rabeprazole sodium market is expected to rise at a considerable CAGR during the forecast. The Rabeprazole sodium helps in reducing heartburn symptoms and other diseases caused by high stomach acids, such as ulcers or reflux, by reducing the quantity of acid produced in the stomach. It’s used to treat gastroesophageal reflux disease (GERD), erosive esophagitis, and other disorders caused by too much stomach acid. The major factor driving the growth of the market include the increasing knowledge of the benefits of rabeprazole sodium and an increase in demand for proton pump inhibitors. Besides, the gastroesophageal reflux disease (GERD) and ulcers cases globally is further surging the growth of the rabeprazole sodium market. As per the Korean Society of Neurogastroenterology and Motility, the prevalence of GERD is 18.1–27.8% in North America, 8.8–25.9% in Europe, 2.5–7.8% in East Asia, 8.7–33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America in 2020. This is estimated to increase during the forecast along with the significant demand for rabeprazole sodium.
The global rabeprazole sodium market is segmented based on type and application. Based on type, the market is sub-segmented into rabeprazole sodium monohydrate and rabeprazole sodium crystalline. . Based on application, the market is sub-segmented into gastroesophageal reflux disease treatment, duodenal ulcer treatment, and others. Among these, the gastroesophageal reflux diseases treatment segment is projected to grow at fastest CAGR during the forecast period. The huge base affected with gastroesophageal reflux diseases creates huge demand for rabeprazole sodium, which in turn drives the segment growth.
To Request a Sample of our Report on Rabeprazole Sodium Market: https://www.omrglobal.com/request-sample/rabeprazole-sodium-market
Rabeprazole Sodium Market Segmentation
By Type
- Rabeprazole Sodium Monohydrate
- Rabeprazole Sodium Crystalline
By Application
- Gastroesophageal Reflux Disease Treatment
- Duodenal Ulcer Treatment
- Others
A full Report of Rabeprazole Sodium Market is Available @ https://www.omrglobal.com/industry-reports/rabeprazole-sodium-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Aytu Therapeutics, Inc.
- Angita Pharma Inc.
- Avadel Pharmaceuticals Plc
- Cadila Pharmaceuticals Ltd.
- CDx Diagnostics
- Enal Drugs Pvt. Ltd.
- Implantica AG
- JSN Chemicals
- Jubilant Pharma Ltd.
- Livzon Pharmaceutical Group
- Shandong Luoxin Pharmaceutical Group Stock co., ltd.
- Syn-Tech Chem & Pharm Co. Ltd.
- Smaart Pharmaceuticals
- Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
- Sterile India Pvt. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/rabeprazole-sodium-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
